Association of ABCB6 Polymorphisms and Serum Levels with Susceptibility to Antituberculosis Drug-induced Hepatotoxicity

被引：0
|
作者：
Chen, Ruina [1 ]
Cheng, Jingru [1 ]
Pan, Hongqiu [2 ]
Lu, Lihuan [3 ]
He, Xiaomin [4 ]
Zhang, Meiling [5 ]
Yi, Honggang [1 ]
Tang, Shaowen [1 ]
机构：
[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China
[2] Jiangsu Univ, Peoples Hosp Zhenjiang 3, Dept TB, Zhenjiang, Peoples R China
[3] Second Peoples Hosp Changshu, Dept TB, Suzhou, Changshu, Peoples R China
[4] Peoples Hosp Taixing, Dept Infect Dis, Taixing, Peoples R China
[5] Jiangsu Univ, Jurong Hosp, Dept Infect Dis, Zhenjiang, Peoples R China
来源：
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES | 2025年 / 34卷 / 01期
基金：
中国国家自然科学基金;
关键词：
antituberculosis drug-induced hepatotoxicity; ATP-binding cassette B6; ABCB6; genetic polymorphisms; case; control study; PROTOPORPHYRIN IX ACCUMULATION; INDUCED LIVER-INJURY; PATHOGENESIS; GUIDELINES;
D O I：
10.15403/jgld-5892
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Background & Aims: The occurrence of anti-tuberculosis drug-induced hepatotoxicity (ATDH) deserves our attention. To explore the role of ATP-binding cassette B6 (ABCB6) polymorphisms and serum levels in the risk of antituberculosis drug-induced hepatotoxicity (ATDH). Methods: A 1:4 matched case-control study was conducted. Four single nucleotide polymorphisms (SNPs) and serum ABCB6 levels were analyzed, and false discovery rate (FDR) was performed to correct for multiple comparison. Results: 224 ATDH cases and 896 controls were included. SNP rs1109867 in ABCB6 gene had a decreased risk of ATDH under dominant models (FDR corrected p-value = 0.027). Furthermore, serum ABCB6 levels at three different times in the ATDH cases were higher than those in the controls. Conclusions: SNP rs1109867 in ABCB6 gene may contribute to the susceptibility to ATDH among patients receiving anti-TB treatment.
引用
收藏
页码：55 / 63
页数：9
相关论文
共 50 条
  • [31] Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation
    Roy, B
    Chowdhury, A
    Kundu, S
    Santra, A
    Dey, B
    Chakraborty, M
    Majumder, PP
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (09) : 1033 - 1037
  • [32] Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis
    Shi, Jing
    Xie, Min
    Wang, Jianmiao
    Xu, Yongjian
    Liu, Xiansheng
    PHARMACOGENOMICS, 2015, 16 (18) : 2083 - 2097
  • [33] NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population
    Lv, Xiaozhen
    Tang, Shaowen
    Xia, Yinyin
    Zhang, Yuan
    Wu, Shanshan
    Yang, Zhirong
    Li, Xiaoting
    Tu, Dehua
    Chen, Yixin
    Deng, Peiyuan
    Ma, Yu
    Chen, Dafang
    Chen, Ru
    Zhan, Siyan
    ANNALS OF HEPATOLOGY, 2012, 11 (05) : 700 - 707
  • [34] N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population
    Mishra, Swapnil
    Daschakraborty, Sunilbaran
    Shukla, Pallavi
    Kapoor, Prerna
    Aggarwal, Rakesh
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (05) : 260 - 265
  • [35] Superoxide Dismutase Gene (SOD 1, SOD2, and SOD3) Polymorphisms and Antituberculosis Drug-induced Hepatitis
    Kim, Sang-Hoon
    Kim, Sang-Heon
    Lee, Jae-Hyoung
    Lee, Byoung-Hoon
    Yoon, Ho Joo
    Shin, Dong Ho
    Park, Sung Soo
    Bin Jang, Suk
    Park, Jae-Seuk
    Jee, Young-Koo
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2015, 7 (01) : 88 - 91
  • [36] Association between NR1I2 polymorphisms and susceptibility to anti- tuberculosis drug -induced hepatotoxicity in an Eastern Chinese Han population: A case -control study
    Yang, Miaomiao
    Pan, Hongqiu
    Chen, Hongbo
    Liu, Wenpei
    Lu, Lihuan
    He, Xiaomin
    Yi, Honggang
    Tang, Shaowen
    INFECTION GENETICS AND EVOLUTION, 2020, 83
  • [37] Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort
    Chen, Ru
    Wang, Jing
    Tang, Shaowen
    Zhang, Yuan
    Lv, Xiaozhen
    Wu, Shanshan
    Xia, Yinyin
    Deng, Peiyuan
    Ma, Yu
    Tu, Dehua
    Chen, Dafang
    Zhan, Siyan
    TUBERCULOSIS, 2015, 95 (01) : 68 - 74
  • [38] Polymorphisms in CYP2E1, GSTM1 and GSTT1 and anti-tuberculosis drug-induced hepatotoxicity
    Brito, Tais C.
    Possuelo, Lia G.
    Valim, Andreia R. M.
    Todendi, Pamela F.
    Ribeiro, Andrezza W.
    Gregianini, Tatiana S.
    Jarczewski, Carla A.
    Hutz, Mara H.
    Rossetti, Maria Lucia R.
    Zaha, Arnaldo
    ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2014, 86 (02): : 855 - 865
  • [39] CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients
    Chanhom, Noppadol
    Wattanapokayakit, Sukanya
    Satproedprai, Nusara
    Suvichapanich, Supharat
    Mahasirimongkol, Surakameth
    Chaikledkaew, Usa
    Udomsinprasert, Wanvisa
    Mushiroda, Taisei
    Jittikoon, Jiraphun
    HELIYON, 2021, 7 (04)
  • [40] HLA-DQ B1*0201 and A1*0102 Alleles Are Not Responsible for Antituberculosis Drug-Induced Hepatotoxicity Risk in Spanish Population
    Leiro-Fernandez, Virginia
    Valverde, Diana
    Vazquez-Gallardo, Rafael
    Constenla-Carames, Lucia
    del Campo-Perez, Victor
    Fernandez-Villar, Alberto
    FRONTIERS IN MEDICINE, 2016, 3
12345